Shandong Keyuan Pharmaceutical Co. Ltd. A Cash Flow-to-Debt Ratio
Shandong Keyuan Pharmaceutical Co. Ltd. A cash flow-to-debt ratio. Shandong Keyuan Pharmaceutical Co. Ltd. A (301281) has a Cash Flow-to-Debt Ratio of -0.31x as of December 2024, meaning its operating cash flow of CN¥-60.52 Million could theoretically repay 0% of its total liabilities (CN¥192.87 Million) in one year. Check Shandong Keyuan Pharmaceutical Co. Ltd. (301281) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Shandong Keyuan Pharmaceutical Co. Ltd. A (2021–2024)
Cash flow-to-debt ratio of Shandong Keyuan Pharmaceutical Co. Ltd. A from 2021 to 2024. Historical debt coverage capacity for Shandong Keyuan Pharmaceutical Co. Ltd. A across 4 annual periods. Check total reinvestment intensity of Shandong Keyuan Pharmaceutical Co. Ltd. to assess the company's total reinvestment commitment from operating cash flow.
Shandong Keyuan Pharmaceutical Co. Ltd. A Cash Flow-to-Debt Ratio by Year (2021–2024)
Shandong Keyuan Pharmaceutical Co. Ltd. A cash flow-to-debt ratio by year from 2021 to 2024. Year-by-year debt coverage analysis for Shandong Keyuan Pharmaceutical Co. Ltd. A. For the full cash flow conversion analysis, see 301281 cash generation efficiency.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.31x | CN¥-60.52 Million | CN¥192.87 Million | ▼ -217.7% |
| 2023 | 0.27x | CN¥37.03 Million | CN¥138.93 Million | ▼ -69.6% |
| 2022 | 0.88x | CN¥115.86 Million | CN¥132.06 Million | ▲ +116.7% |
| 2021 | 0.40x | CN¥52.02 Million | CN¥128.52 Million | — |